Literature DB >> 23736140

Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.

Amit Patel, Umeer Waheed, Stephen J Brett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23736140     DOI： 10.1007/s00134-013-2962-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  "Colloid twice daily" is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence.

Authors:  Peter Kranke; Norbert Roewer; Ralf M Muellenbach
Journal:  Intensive Care Med       Date:  2013-06-05       Impact factor: 17.440

Review 2.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

3.  Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial.

Authors:  Martin Dolecek; Petr Svoboda; Ilona Kantorová; Peter Scheer; Igor Sas; Jitka Bíbrová; Jana Radvanova; Martin Radvan
Journal:  Hepatogastroenterology       Date:  2009 Nov-Dec

Review 4.  Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.

Authors:  Ryan Zarychanski; Ahmed M Abou-Setta; Alexis F Turgeon; Brett L Houston; Lauralyn McIntyre; John C Marshall; Dean A Fergusson
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

Review 5.  Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.

Authors:  David J Gattas; Arina Dan; John Myburgh; Laurent Billot; Serigne Lo; Simon Finfer
Journal:  Intensive Care Med       Date:  2013-02-14       Impact factor: 17.440

Review 6.  Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  Nicolai Haase; Anders Perner; Louise Inkeri Hennings; Martin Siegemund; Bo Lauridsen; Mik Wetterslev; Jørn Wetterslev
Journal:  BMJ       Date:  2013-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.